ROLE OF INSULIN RESISTANCE IN PREDICTING DEATH OF PATIENTS WITH DYSFUNCTION OF MULTIPLE VITAL ORGANS
Not Applicable
- Conditions
- Health Condition 1: R69- Illness, unspecified
- Registration Number
- CTRI/2019/06/019732
- Lead Sponsor
- ONE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Aged 18 - 60years
2.Involvement of two or more dysfunctional organs.
3.Availability of blood samples to determine fasting insulin and glucose within two hours after ICU admission.
Exclusion Criteria
1.Patients with pre-existing diabetes mellitus, chronic renal failure malignancy, cirrhosis and autoimmune disorders.
2.Patients on corticosteroid therapy
3.Patients with pancreatitis
4.Inability to give consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MORTALITY PREDICTION USING INSULIN RESISTANCE ( HOMA IR )Timepoint: ADMISSION TO 28 DAYS
- Secondary Outcome Measures
Name Time Method APACHE IITimepoint: ON ICU ADMISSION (DAY 1);CAUSE OF ICU ADMISSIONTimepoint: ON ICU ADMISSION (DAY 1);COMORBIDITYTimepoint: ON ICU ADMISSION (DAY 1);ICU FREE DAYSTimepoint: DAY TO WARD TRANSFER-28 DAYS OR DEATH WHICHEVER EARLIER;INSULIN SENSITIVITY (QUICKI INDEX)Timepoint: ON ICU ADMISSION (DAY 1);LENGTH OF ICU STAYTimepoint: ON ICU ADMISSION (DAY 1) TO WARD TRANSFER, DEATH OR 28 DAYS WHICHEVER EARLIER;MECHANICAL VENTILATION DAYSTimepoint: ON ICU ADMISSION (DAY 1) TO WARD TRANSFER, DEATH OR 28 DAYS WHICHEVER EARLIER;MORTALITYTimepoint: ON ICU ADMISSION (DAY 1)-28 DAYS;NUMBER AND TYPE OF ORGAN FAILURESTimepoint: ON ICU ADMISSION (DAY 1);VASOPRESSOR USETimepoint: ON ICU ADMISSION (DAY 1) TO WARD TRANSFER, DEATH OR 28 DAYS WHICHEVER EARLIER